Shanglei Ning
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Hepatology top 10%
Papers in
- Surgery 14
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
- Pancreatic function and diabetes 4
-
- Receptor Mechanisms and Signaling 3
- Protein Tyrosine Phosphatases 2
- Co-authors
- Yunfei Xu (8 shared papers)Yun Zhang (1 shared paper)Pengyuan Yang (1 shared paper)Dong Xie (1 shared paper)Qi-Jing Li (1 shared paper)Jiang‐Sha Zhao (1 shared paper)Xiao-Fan Wang (1 shared paper)Shan Jiang (1 shared paper)
- Journals
- British Journal of Pharmacology (2 papers)Cell Metabolism (1 paper)British Journal of Cancer (1 paper)Annals of Vascular Surgery (1 paper)Cell Research (1 paper)
- Partner nations
- ChinaUnited StatesPortugal
In The Last Decade
Shanglei Ning
27 papers receiving 1.2k citations
Shanglei Ning's Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 400
- Hepatology 104
- Oncology 329
- Molecular Biology 695
- Immunology 186
Countries citing papers authored by Shanglei Ning
This map shows the geographic impact of Shanglei Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanglei Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanglei Ning more than expected).
Fields of papers citing papers by Shanglei Ning
This network shows the impact of papers produced by Shanglei Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanglei Ning. The network helps show where Shanglei Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Shanglei Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma Hit paper breakdown → | 2012 | 456 |
| 2 | 2014 | 80 | |
| 3 | 2016 | 75 | |
| 4 | 2014 | 67 | |
| 5 | 2018 | 64 | |
| 6 | 2017 | 56 | |
| 7 | 2022 | 39 | |
| 8 | 2018 | 36 | |
| 9 | 2012 | 33 | |
| 10 | 2017 | 32 | |
| 11 | 2018 | 32 | |
| 12 | 2015 | 30 | |
| 13 | 2013 | 29 | |
| 14 | 2018 | 29 | |
| 15 | 2014 | 27 | |
| 16 | 2010 | 22 | |
| 17 | 2020 | 13 | |
| 18 | 2017 | 10 | |
| 19 | 2023 | 10 | |
| 20 | 2016 | 10 |
About Shanglei Ning
Shanglei Ning is a scholar working on Surgery, Molecular Biology, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Pancreatic function and diabetes (4 papers), Cancer-related molecular mechanisms research (4 papers), Receptor Mechanisms and Signaling (3 papers), Diabetes and associated disorders (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Diabetes Management and Research (2 papers) and Protein Tyrosine Phosphatases (2 papers). The work is most often cited by research in Cancer Research (400 citations), Hepatology (104 citations), Oncology (329 citations), Molecular Biology (695 citations) and Immunology (186 citations). Shanglei Ning has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Yunfei Xu, Yun Zhang, Pengyuan Yang, Dong Xie, Qi-Jing Li, Jiang‐Sha Zhao, Xiao-Fan Wang, Shan Jiang, Yunfei Yuan and Yuezhen Deng. Their work appears in journals such as British Journal of Pharmacology, Cell Metabolism, British Journal of Cancer, Annals of Vascular Surgery and Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.